CoChat

Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy

Open access
Xi, Chenxiang, Yan, Zihui, Bai, Dandan, Zhang, Yalin, Wang, Beiying, Han, Xiaoxiao, Wu, Li, Shi, Xiaohui, Hu, Zhiyi, Tang, Ming, Su, Zhongqu, Liu, Yingdong, Liu, Binya, Yin, Jiqing, Wang, Hong, Li, Xiaocui, Zhang, Yanping, Gao, Shaorong, Liu, Wenqiang · 2024 · Protein & Cell

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

The current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) remains a threat to pregnant women. However, the impact of early pregnancy SARS-CoV-2 infection on the maternal-fetal interface remains poorly understood. Here, we present a comprehensive analysis of single-cell transcriptomics and metabolomics in placental samples infected with SARS-CoV-2 during early pregnancy. Compared to control placentas, SARS-CoV-2 infection elicited immune responses at the maternal-fetal interface and induced metabolic alterations in amino acid and phospholipid profiles during the initial weeks post-infection. However, subsequent immune cell activation and heightened immune tolerance in trophoblast cells established a novel dynamic equilibrium that mitigated the impact on the maternal-fetal interface. Notably, the immune response and metabolic alterations at the maternal-fetal interface exhibited a gradual decline during the second trimester. Our study underscores the adaptive immune tolerance mechanisms and establishment of immunological balance during the first two trimesters following maternal SARS-CoV-2 infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/procel/pwae006

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Characteristics of the study population and single-cell transcriptome profiles of the maternal-fetal interface. (A) Experimental design for the study. Placentas were collected from healthy donors and SARS-CoV-2-infected pregnancies. The decidua and chorion were separated and processed by mechanical and enzymatic methods to isolate single cells, which were multiplexed and profiled using single-cell RNA sequencing. (B) UMAP plots of first-trimester chorion tissues colored by cell type. (C) UMAP plots of first-trimester decidua tissues colored by cell type. (D) Bubble plots of key gene expression markers used for annotations of cells from first-trimester chorion and decidua tissues. (E) HE staining of decidua and chorion tissues from the first trimester. Scale bar = 200 μm.
Figure 1. Characteristics of the study population and single-cell transcriptome profiles of the maternal-fetal interface. (A) Experimental design for the study. Placentas were collected from healthy donors and SARS-CoV-2-infected pregnancies. The decidua and chorion were separated and processed by mechanical and enzymatic methods to isolate single cells, which were multiplexed and profiled using single-cell RNA sequencing. (B) UMAP plots of first-trimester chorion tissues colored by cell type. (C) UMAP plots of first-trimester decidua tissues colored by cell type. (D) Bubble plots of key gene expression markers used for annotations of cells from first-trimester chorion and decidua tissues. (E) HE staining of decidua and chorion tissues from the first trimester. Scale bar = 200 μm.CC BY · PubMed Central
Figure 2. SARS-CoV-2 induces a wide range of antiviral responses at the maternal-fetal interface. (A) Volcano plot showing the DEGs in immune cells of decidual tissues from pregnant women infected with SARS-CoV-2. (B) Gene Ontology (GO) enrichment analysis of upregulated and downregulated DEGs in immune cells of decidua tissues from pregnant women infected with SARS-CoV-2. (C) Violin plots of select DEGs in different cell types of the first-trimester control and COVID-19 groups. Expression levels were transformed using logarithm. ** represents P < 0.01. (D) The differential interaction strength between immune cells and trophoblast cells. All the interaction strength between specific cells decreased in the COVID-19 group.
Figure 2. SARS-CoV-2 induces a wide range of antiviral responses at the maternal-fetal interface. (A) Volcano plot showing the DEGs in immune cells of decidual tissues from pregnant women infected with SARS-CoV-2. (B) Gene Ontology (GO) enrichment analysis of upregulated and downregulated DEGs in immune cells of decidua tissues from pregnant women infected with SARS-CoV-2. (C) Violin plots of select DEGs in different cell types of the first-trimester control and COVID-19 groups. Expression levels were transformed using logarithm. ** represents P < 0.01. (D) The differential interaction strength between immune cells and trophoblast cells. All the interaction strength between specific cells decreased in the COVID-19 group.CC BY · PubMed Central
Figure 3. SARS-CoV-2 leads to limited activation of immune cells. (A) UMAP plot showing the expression level of CD45 in cells from first-trimester decidua tissues. (B) UMAP plot of CD45+ cells from first-trimester decidua tissues. (C) Bubble plots of key gene expression markers used for annotations of immune cells from first-trimester decidua tissues. (D) Bubble plot showing ligand–receptor interactions among NKCs and MACs of the first-trimester control and COVID-19 groups. (E) Stacked bar plot showing percentages of different immune cell types between the first-trimester control and COVID-19 groups. (F) Immunofluorescence staining of CD45 and CD14 (MAC markers) in the decidua (left panel) and a bar plot showing the percentage of MACs between the first-trimester control and COVID-19 groups. Scale bar = 50 μm. (G) Violin plots of select DEGs in MACs of the first-trimester control and COVID-19 groups. Expression levels were transformed using logarithm. ** represents P < 0.01.
Figure 3. SARS-CoV-2 leads to limited activation of immune cells. (A) UMAP plot showing the expression level of CD45 in cells from first-trimester decidua tissues. (B) UMAP plot of CD45+ cells from first-trimester decidua tissues. (C) Bubble plots of key gene expression markers used for annotations of immune cells from first-trimester decidua tissues. (D) Bubble plot showing ligand–receptor interactions among NKCs and MACs of the first-trimester control and COVID-19 groups. (E) Stacked bar plot showing percentages of different immune cell types between the first-trimester control and COVID-19 groups. (F) Immunofluorescence staining of CD45 and CD14 (MAC markers) in the decidua (left panel) and a bar plot showing the percentage of MACs between the first-trimester control and COVID-19 groups. Scale bar = 50 μm. (G) Violin plots of select DEGs in MACs of the first-trimester control and COVID-19 groups. Expression levels were transformed using logarithm. ** represents P < 0.01.CC BY · PubMed Central
Figure 4. Immune tolerance in trophoblast cells is enhanced. (A) Violin plots of HLA-G in trophoblast cells of the first-trimester control and COVID-19 groups. Expression levels were transformed using logarithm. ** represents P < 0.01. (B) Immunohistochemistry and the immunohistochemistry score of HLA-G in chorion tissues of the first-trimester control and COVID-19 groups. Scale bar = 100 μm. (C) Bubble plot showing ligand–receptor interactions among NKCs and EVTs of the first-trimester control and COVID-19 groups. (D) RNA velocity streamlines embedded on the UMAP plot of SCTs, EVTs, and VCTs from first-trimester chorion tissues. (E) Violin plots of select DEGs in SCTs of the first-trimester control and COVID-19 groups. Expression levels were transformed using logarithm. ** represents P < 0.01. (F) Box plot showing the cytokine scores of different cell types between the control and COVID-19 groups. The mean ± SD of each group is shown in the plot.
Figure 4. Immune tolerance in trophoblast cells is enhanced. (A) Violin plots of HLA-G in trophoblast cells of the first-trimester control and COVID-19 groups. Expression levels were transformed using logarithm. ** represents P < 0.01. (B) Immunohistochemistry and the immunohistochemistry score of HLA-G in chorion tissues of the first-trimester control and COVID-19 groups. Scale bar = 100 μm. (C) Bubble plot showing ligand–receptor interactions among NKCs and EVTs of the first-trimester control and COVID-19 groups. (D) RNA velocity streamlines embedded on the UMAP plot of SCTs, EVTs, and VCTs from first-trimester chorion tissues. (E) Violin plots of select DEGs in SCTs of the first-trimester control and COVID-19 groups. Expression levels were transformed using logarithm. ** represents P < 0.01. (F) Box plot showing the cytokine scores of different cell types between the control and COVID-19 groups. The mean ± SD of each group is shown in the plot.CC BY · PubMed Central
Figure 5. The impact of SARS-CoV-2 on the maternal-fetal interface gradually diminishes with development. (A) UMAP plots of second-trimester placental tissues colored by cell type. (B) Bubble plots of key gene expression markers used for annotation of cells from second-trimester placental tissues. (C) RNA velocity streamlines embedded on the UMAP plot of SCTs, EVTs and VCTs from first-trimester chorion tissues and second-trimester placental tissues. (D) Immunohistochemistry and the immunohistochemistry score of HLA-G in the placental tissues of the second-trimester control and COVID-19 groups. Scale bar = 100 μm. (E) Sankey plot showing DEG changes in EVTs between first-trimester and second-trimester tissues. NS means no significance.
Figure 5. The impact of SARS-CoV-2 on the maternal-fetal interface gradually diminishes with development. (A) UMAP plots of second-trimester placental tissues colored by cell type. (B) Bubble plots of key gene expression markers used for annotation of cells from second-trimester placental tissues. (C) RNA velocity streamlines embedded on the UMAP plot of SCTs, EVTs and VCTs from first-trimester chorion tissues and second-trimester placental tissues. (D) Immunohistochemistry and the immunohistochemistry score of HLA-G in the placental tissues of the second-trimester control and COVID-19 groups. Scale bar = 100 μm. (E) Sankey plot showing DEG changes in EVTs between first-trimester and second-trimester tissues. NS means no significance.CC BY · PubMed Central
Figure 6. The metabolic changes caused by SARS-CoV-2 infection gradually diminish during placental development. (A) Experimental design for untargeted metabolomic analysis. (B) The stacked bar plot showing the counts of differentially regulated metabolites in each group. (C) PCA plots of the samples from three tissues. (D) KEGG analysis of differentially regulated metabolites from three tissues. (E) The diagram of arginine biosynthesis and the normalized levels of some metabolites in control and COVID-19 groups from first-trimester chorion tissues and second-trimester placental tissues. * and ** represent P < 0.05 and P < 0.01, respectively. (F) Violin plots of genes related to arginine biosynthesis in control and COVID-19 groups from first-trimester chorion tissues and second-trimester placental tissues. Expression levels were transformed using logarithm.
Figure 6. The metabolic changes caused by SARS-CoV-2 infection gradually diminish during placental development. (A) Experimental design for untargeted metabolomic analysis. (B) The stacked bar plot showing the counts of differentially regulated metabolites in each group. (C) PCA plots of the samples from three tissues. (D) KEGG analysis of differentially regulated metabolites from three tissues. (E) The diagram of arginine biosynthesis and the normalized levels of some metabolites in control and COVID-19 groups from first-trimester chorion tissues and second-trimester placental tissues. * and ** represent P < 0.05 and P < 0.01, respectively. (F) Violin plots of genes related to arginine biosynthesis in control and COVID-19 groups from first-trimester chorion tissues and second-trimester placental tissues. Expression levels were transformed using logarithm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 18

Metadata

Authors
Xi, C., Yan, Z., Bai, D., Zhang, Y., Wang, B., Han, X., Wu, L., Shi, X., Hu, Z., Tang, M., Su, Z., Liu, Y., Liu, B., Yin, J., Wang, H., Li, X., Zhang, Y., Gao, S., & Liu, W.
Affiliations
  • Tongji University (CN)
  • Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University , Shanghai 200092 , China
Corresponding author
  • Li, Xiaocui
  • Zhang, Yanping
  • Gao, Shaorong
  • Liu, Wenqiang
Venue
Protein & Cell
Published
2024-03-05
Volume
15
Issue
6
Pages
460-473
ISSN
  • 1674-800X (ISSN-L)
  • 1674-8018
OpenAlex
W4392474156
Cited by
18
References
47
Citations by year
2026: 7 · 2025: 5 · 2024: 6
FWCI
9.97
Type
journal article
Language
en
Open access
Locations
  • Protein & Cell (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Ministry of Science and Technology of China (2022YFC2702200, 2021YFA1102900)
  • National Natural Science Foundation of China (82022027, 32270909, 31721003, 92168205, 31871448, 31820103009, 32300684)
  • Science and Technology of Shanghai Municipality (19JC1415300, 21JC1405500)
  • Shanghai Municipal Medical and Health Discipline Construction Projects (2017ZZ02015)
  • China Postdoctoral Science Foundation (2023M732660, GZB20230523)
  • Shanghai Municipal Health (20214Y0254)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
COVID-19 pandemic, COVID-19 in pregnancy, maternal-fetal interface, placenta, early pregnancy, immune tolerance, trophoblast, immune cell activation, amino acid metabolism, phospholipid metabolism, placental metabolomics, single-cell transcriptomics
MeSH terms
COVID-19, SARS-CoV-2, Adult, Female, Humans, Immune Tolerance, Placenta, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Trimester, First, Trophoblasts, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy. https://app.cochat.ai/papers/10.1093/procel/pwae006
The paper
Xi, C., Yan, Z., Bai, D., Zhang, Y., Wang, B., Han, X., Wu, L., Shi, X., Hu, Z., Tang, M., Su, Z., Liu, Y., Liu, B., Yin, J., Wang, H., Li, X., Zhang, Y., Gao, S., & Liu, W. (2024). Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy. Protein & Cell. https://doi.org/10.1093/procel/pwae006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.